Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
RASD2 encodes a Ras-related protein that enriched in striatum. Zusätzlich bieten wir Ihnen RASD Family, Member 2 Antikörper (95) und viele weitere Produktgruppen zu diesem Protein an.
Showing 7 out of 8 products:
Human RASD2 Protein expressed in Wheat germ - ABIN1317482
Harrison, Lahoste, Ruskin: Ontogeny and dopaminergic regulation in brain of Ras homolog enriched in striatum (Rhes). in Brain research 2008
results support the hypothesis that Rhes expression is regulated by miRNA and indicate that miR-101 may be a potent modulator of Rhes expression in striatal neurons.
Study demonstrated that variation in the gene coding for RASD2 (rs6518956) affects in vivo prefrontal and striatal phenotypes in healthy human subjects that are relevant to schizophrenia
Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion
Findings reveal that ras homolog enriched in striatum is localized also in striatal cholinergic interneurons and, most importantly, lack of this G-protein, significantly alters dopamine D2 receptor modulation of striatal cholinergic excitability.
Rhes is reduced in the brains of Huntington's disease patients.
The findings of this study suggested that Rhes may play a crucial role in striatal iron homeostasis.
Rhes robustly binds the autophagy regulator Beclin-1, decreasing its inhibitory interaction with Bcl-2 independent of JNK-1 signaling.
The sequestering of Rhes through its binding to mutant huntingtin may decrease the ability of Rhes to perform vital physiological functions in the striatum neurons of Huntington disease patients. (Review)
Rhes is an imidazoline-regulated transcript in pancreatic beta-cells
Rhes can interfere with the functional activity of wt and mutated TSHr and with the respective hormone-stimulated cAMP production of FSHr and LHr.
The genes RASD2 might be vulnerability genes for neuropsychologically defined subgroups of schizophrenic patients.
The monomeric G proteins AGS1 and Rhes selectively influence Galphai-dependent signaling to modulate N-type (CaV2.2) calcium channels.
Binding to the Gbeta subunits involves the cationic regions of AGS1 and Rhes, and Data used Rhes-AGS1 chimeras to show that their different cationic regions determine the Gbeta-specificity of the interactions.
guanine nucleotide exchange factor RasGRP1 inhibited Rhes-mediated control of striatal motor activity in mice. RasGRP1 stabilized Rhes, increasing its synaptic accumulation in the striatum.
that Rasd2 mutants display deficits in basal prepulse inhibition that, in turn, exacerbate gating disruption under psychotomimetic drug challenge
Study showed that both genetic deletion of Rhes and pharmacological blockade of mTORC1 significantly attenuate dyskinesia development by reducing the sensitization of striato-nigral medium-sized spiny neurons to levodopa
ectopic expression of Rhes in the cerebellum of N171-82Q mice, during the asymptomatic period led to an exacerbation of motor deficits, including loss of balance and motor incoordination with ataxia-like features
Brain Rhes expression is decreased in a mouse model of Huntington's disease.
Rhes is necessary for Akt dephosphorylation by the striatal multi-protein complex
behavioral symptoms of HD are regulated by Rhes
This study demonstrated that Rhes-deleted mice are dramatically protected from neurotoxicity and motor dysfunction in a striatal-specific model of Huntington's disease elicited by 3-nitropropionic acid.
Ths results of this study indicted that Rhes physiologically binds to and activates mTOR in the striatum and L-DOPA-induced dyskinesia.
Rhes disruption affects selected behavioral competencies, including a gender-dependent increase in anxiety levels and a clear motor coordination deficit but no learning or memory impairment.
The absence of Rhes modulates cAMP/PKA signalling in both striatopallidal and striatonigral projection neurons by increasing Golf protein levels and, in turn, influencing motor responses challenged by dopaminergic agonist/antagonist.
This gene encodes a Ras-related protein that enriched in striatum. The product of this gene binds to GTP and possesses intrinsic GTPase activity. The gene belongs to the Ras superfamily of small GTPases. The exact function of this gene is unknown, but most striatum-specific mRNAs characterized to date encode components of signal transduction cascades.
RASD family, member 2
, GTP-binding protein Rhes
, Ras homolog enriched in striatum
, tumor endothelial marker 2
, ras homolog enriched in striatum